Human Tissue Factor Pathway Inhibitor (TFPI) AssayMax ELISA KitHuman Tissue Factor Pathway Inhibitor (TFPI) AssayMax ELISA Kit
Move your mouse over image or click to enlarge

Human Tissue Factor Pathway Inhibitor (TFPI) AssayMax ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

Cat# Size Price Qty Buy
ET1005-1 96 Well Plate £276.25

Additional Information

Property Value or Rating
Manufacturer Assaypro, LLC.
Product Type AssayMax™ ELISA Kits
Samples Serum, Milk, Cell Culture, CSF
Species Human
Reactivity Human
Assay Format Sandwich ELISA
Product Size 96 Well Plate
Range 0.156-10 ng/ml
Plex Number 1
Storage Refer to component labels for details
Entrez Gene 7035
Omim 152310
UniProt P10646
UniGene Hs.516578
Special Notes For Research Use Only, Not To Be Used For Diagnostic Purposes
References * Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339 
* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 
* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 
* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11. 
* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA 

" title="

* Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339 
* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 
* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 
* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11. 
* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA 

" target="_blank">

* Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339 
* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 
* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 
* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11. 
* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA 

Related Documents